This, in addition to the prognostic value of PKM2/PKM1 revealed by our analysis of the TCGA sarcoma cohort, led us to postulate that expression of PKM2 may play a role in malignant transformation of skeletal muscle tissue to form STS. The gene discussed is PKM; the disease is sarcoma.